Immunovant, Inc. Warrants expiring 12/18/2024

YTD

ALL

Why Robinhood?

You can watch IMVTW and buy or sell other stocks, ETFs, and their options commission-free!

About IMVTW

Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It is developing a novel, fully human monoclonal antibody IMVT-1401 that selectively binds to and inhibits the neonatal fragment crystallizable receptor.

CEO

Eric Venker, MD, PharmD

CEOEric Venker, MD, PharmD

Employees

—

Employees—

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2018

Founded2018

Employees

—

Employees—

IMVTW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

—

52 Week high—

52 Week low

—

52 Week low—

Stock Snapshot

The current Immunovant, Inc. Warrants expiring 12/18/2024(IMVTW) stock price is $6.86.

Immunovant, Inc. Warrants expiring 12/18/2024(IMVTW) stock opened on 2025-12-06 at —. The price climbed to — and dipped to —.

Immunovant, Inc. Warrants expiring 12/18/2024(IMVTW) shares are trading with a volume of 0.